IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission.

AuthorsJohn G Ryan, Heleen D de Koning, Lisa A Beck, Matthew G Booty, Daniel L Kastner, Anna Simon
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 121 Issue 1 Pg. 260-2 (Jan 2008) ISSN: 1097-6825 [Electronic] United States
PMID17936890 (Publication Type: Case Reports, Letter, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antirheumatic Agents
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1
  • Antirheumatic Agents (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Interleukin 1 Receptor Antagonist Protein (administration & dosage, therapeutic use)
  • Interleukin-1 (antagonists & inhibitors)
  • Middle Aged
  • Schnitzler Syndrome (diagnosis, drug therapy, pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: